Cargando…

Genome-wide DNA methylation and RNA-seq analyses identify genes and pathways associated with doxorubicin resistance in a canine diffuse large B-cell lymphoma cell line

Doxorubicin resistance is a major challenge in the successful treatment of canine diffuse large B-cell lymphoma (cDLBCL). In the present study, MethylCap-seq and RNA-seq were performed to characterize the genome-wide DNA methylation and differential gene expression patterns respectively in CLBL-1 8....

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsu, Chia-Hsin, Tomiyasu, Hirotaka, Liao, Chi-Hsun, Lin, Chen-Si
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104391/ https://www.ncbi.nlm.nih.gov/pubmed/33961622 http://dx.doi.org/10.1371/journal.pone.0250013

Ejemplares similares

Canine diffuse large B-cell lymphoma downregulates the activity of CD8 + T-cells through tumor-derived extracellular vesicles
por: Weng, Hsin-Pei, et al.
Publicado: (2023)

Comparative Aspects of Molecular Mechanisms of Drug Resistance through ABC Transporters and Other Related Molecules in Canine Lymphoma
por: Tomiyasu, Hirotaka, et al.
Publicado: (2015)

Changes in gene expression profiles and cytokine secretions in peripheral monocytes by treatment with small extracellular vesicles derived from a canine lymphoma cell line
por: TANI, Akiyoshi, et al.
Publicado: (2022)

Comprehensive gene expression analysis of canine invasive urothelial bladder carcinoma by RNA-Seq
por: Maeda, Shingo, et al.
Publicado: (2018)

Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma
por: Al-Nadaf, Sami, et al.
Publicado: (2018)

Celecoxib Prevents Doxorubicin-Induced Multidrug Resistance in Canine and Mouse Lymphoma Cell Lines
por: Karai, Edina, et al.
Publicado: (2020)

Canine transmissible venereal tumour established in immunodeficient mice reprograms the gene expression profiles associated with a favourable tumour microenvironment to enable cancer malignancy
por: Ke, Chiao-Hsu, et al.
Publicado: (2022)

Alternating Rabacfosadine/Doxorubicin: Efficacy and Tolerability in Naïve Canine Multicentric Lymphoma
por: Thamm, D.H., et al.
Publicado: (2017)

Investigation of canine extracellular vesicles in diffuse large B-cell lymphomas
por: Kulka, Marek, et al.
Publicado: (2022)

Genome-wide DNA methylation analysis in canine gastrointestinal lymphoma
por: OHTA, Hiroshi, et al.
Publicado: (2020)

Mutational landscape of canine B-cell lymphoma profiled at single nucleotide resolution by RNA-seq
por: Giannuzzi, Diana, et al.
Publicado: (2019)

Epigenetic Silencing of TFPI-2 in Canine Diffuse Large B-Cell Lymphoma
por: Ferraresso, Serena, et al.
Publicado: (2014)

miRNome expression analysis in canine diffuse large B-cell lymphoma
por: Elshafie, Nelly O., et al.
Publicado: (2023)

The Regulation of the Expression of ABCG2 Gene through Mitogen-Activated Protein Kinase Pathways in Canine Lymphoid Tumor Cell Lines
por: TOMIYASU, Hirotaka, et al.
Publicado: (2013)

Evaluation of the drug sensitivity and expression of 16 drug resistance-related genes in canine histiocytic sarcoma cell lines
por: ASADA, Hajime, et al.
Publicado: (2015)

Comprehensive analysis of miRNA and protein profiles within exosomes derived from canine lymphoid tumour cell lines
por: Asada, Hajime, et al.
Publicado: (2019)

Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in diffuse large B-cell lymphoma
por: Candelaria, Myrna, et al.
Publicado: (2021)

Single-Cell RNA-Seq and Bulk RNA-Seq Reveal Intratumoral Heterogeneity and Tumor Microenvironment Characteristics in Diffuse Large B-Cell Lymphoma
por: Zhao, Yang, et al.
Publicado: (2022)

Cytotoxic Activity of Melatonin Alone and in Combination with Doxorubicin and/or Dexamethasone on Diffuse Large B-Cell Lymphoma Cells in In Vitro Conditions
por: Mańka, Sylwia, et al.
Publicado: (2023)

Methadone does not potentiate the effect of doxorubicin in canine tumour cell lines
por: Cueni, Claudia, et al.
Publicado: (2020)

Characteristics of Extranodal NK/T-Cell Lymphoma, Nasal Type, Compared with Nasal Diffuse Large B-cell Lymphoma
por: Tanaka, Hirotaka, et al.
Publicado: (2023)

RNA-Seq analysis of gene expression in 25 cases of canine lymphoma undergoing CHOP chemotherapy
por: Mee, Miles W., et al.
Publicado: (2022)

MDR1 Inhibition Reverses Doxorubicin-Resistance in Six Doxorubicin-Resistant Canine Prostate and Bladder Cancer Cell Lines
por: Packeiser, Eva-Maria, et al.
Publicado: (2023)

Canine Lymphoma, More Than a Morphological Diagnosis: What We Have Learned about Diffuse Large B-Cell Lymphoma
por: Aresu, Luca
Publicado: (2016)

Sorafenib and Doxorubicin Show Synergistic Effects in Human and Canine Osteosarcoma Cell Lines
por: Yang, Ya-Ting, et al.
Publicado: (2022)

Flow Cytometry in the Diagnosis of Canine T-Cell Lymphoma
por: Comazzi, Stefano, et al.
Publicado: (2021)

The histone deacetylase inhibitor panobinostat is a potent antitumor agent in canine diffuse large B-cell lymphoma
por: Dias, Joana N.R., et al.
Publicado: (2018)

Evaluation of 41 single nucleotide polymorphisms in canine diffuse large B-cell lymphomas using MassARRAY
por: Sirivisoot, Sirintra, et al.
Publicado: (2022)

POT1 mutations are frequent and associated with Ki-67 index in canine diffuse large B-cell lymphoma
por: Fanelli, Antonella, et al.
Publicado: (2022)

Computed tomography may detect liver infiltration of canine diffuse hepatic lymphoma
por: Tanaka, Toshiyuki, et al.
Publicado: (2021)

DNA methylation profiling reveals common signatures of tumorigenesis and defines epigenetic prognostic subtypes of canine Diffuse Large B-cell Lymphoma
por: Ferraresso, Serena, et al.
Publicado: (2017)

Clinical characteristics and outcomes of Mott cell lymphoma in nine miniature dachshunds
por: Ohmi, Aki, et al.
Publicado: (2022)

Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma
por: Arthur, Sarah E., et al.
Publicado: (2018)

Prognostic impact of sarcopenia in patients with diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
por: Go, Se‐Il, et al.
Publicado: (2016)

Genome-Wide ChIP-seq and RNA-seq Analyses of STAT3 Target Genes in TLRs Activated Human Peripheral Blood B Cells
por: Wu, Jing, et al.
Publicado: (2022)

Dendritic cell vaccination plus low-dose doxorubicin for the treatment of spontaneous canine hemangiosarcoma
por: Konduri, V., et al.
Publicado: (2019)

The intratumor heterogeneity of TP53 gene mutations in canine histiocytic sarcoma
por: ASADA, Hajime, et al.
Publicado: (2019)

Genome-Wide Analyses Suggest Mechanisms Involving Early B-Cell Development in Canine IgA Deficiency
por: Olsson, Mia, et al.
Publicado: (2015)

Are B‐symptoms more reliable prognostic indicators than substage in canine nodal diffuse large B‐cell lymphoma
por: Škor, Ondřej, et al.
Publicado: (2020)

Doxorubicin treatment modulates chemoresistance and affects the cell cycle in two canine mammary tumour cell lines
por: Levi, Michela, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o9b6263qv9a1qhfsclm7l6944r